CD28 promotes plasma cell survival, sustained antibody responses, and BLIMP-1 upregulation through its distal PYAP proline motif

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4717-4728

  Rozanski, Cheryl H ^a   Utley, Adam ^a   Carlson, Louise M ^a   Farren, Matthew R ^a   Murray, Megan ^a   Russell, Lisa M ^b   Nair, Jayakumar R ^a   Yang, ZhengYu ^a   Brady, William ^a   Garrett Sinha, Lee Ann ^b   Schoenberger, Stephen P ^c   Green, Jonathan M ^d   Boise, Lawrence H ^e   Lee, Kelvin P ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLIPASE C; PROLINE; PROTEIN KINASE B; PROTEIN KINASE LCK; VAV PROTEIN; PRDM1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GERMINAL CENTER; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; MUTANT MOUSE STRAIN; REAL TIME POLYMERASE CHAIN REACTION;

AMINO ACID MOTIFS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD28; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOPRECIPITATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PLASMA CELLS; PROLINE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84929104918     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402260     Document Type: Article

References (54)

1. Radbruch, A., G. Muehlinghaus, E. O. Luger, A. Inamine, K. G. Smith, T. Dörner, and F. Hiepe. 2006. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6: 741-750.
2. Arce, S., G. Cassese, A. Hauser, T. Dörner, M. Odendahl, R. Manz, A. Radbruch, and F. Hiepe. 2002. The role of long-lived plasma cells in autoimmunity. Immunobiology 206: 558-562.
3. Luger, E. O., M. Wegmann, G. Achatz, M. Worm, H. Renz, and A. Radbruch. 2010. Allergy for a lifetime? Allergol. Int. 59: 1-8.
4. Slifka, M. K., and R. Ahmed. 1998. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10: 252-258.
5. Tangye, S. G. 2011. Staying alive: regulation of plasma cell survival. Trends Immunol. 32: 595-602.
6. Amanna, I. J., N. E. Carlson, and M. K. Slifka. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357: 1903-1915.
7. Ahuja, A., S. M. Anderson, A. Khalil, and M. J. Shlomchik. 2008. Maintenance of the plasma cell pool is independent of memory B cells. Proc. Natl. Acad. Sci. USA 105: 4802-4807.
8. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
9. Looney, R. J., J. H. Anolik, D. Campbell, R. E. Felgar, F. Young, L. J. Arend, J. A. Sloand, J. Rosenblatt, and I. Sanz. 2004. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 50: 2580-2589.
10. Mahévas, M., P. Patin, F. Huetz, M. Descatoire, N. Cagnard, C. Bole-Feysot, S. Le Gallou, M. Khellaf, O. Fain, D. Boutboul, et al. 2013. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J. Clin. Invest. 123: 432-442.
11. Racine, R., M. McLaughlin, D. D. Jones, S. T. Wittmer, K. C. MacNamara, D. L. Woodland, and G. M. Winslow. 2011. IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J. Immunol. 186: 1011-1021.
12. Reynolds, A., M. Kuraoka, and G. Kelsoe. 2013. Natural IgM is produced by B1a cell-derived bone marrow plasma cells that do not share a survival niche with IgG AFC. J. Immunol. 190: 74. 16 (Abstr.).
13. Chu, V. T., A. Fröhlich, G. Steinhauser, T. Scheel, T. Roch, S. Fillatreau, J. J. Lee, M. Löhning, and C. Berek. 2011. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat. Immunol. 12: 151-159.
14. Rozanski, C. H., R. Arens, L. M. Carlson, J. Nair, L. H. Boise, A. A. Chanan-Khan, S. P. Schoenberger, and K. P. Lee. 2011. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med. 208: 1435-1446.
15. Peperzak, V., I. Vikström, J. Walker, S. P. Glaser, M. LePage, C. M. Coquery, L. D. Erickson, K. Fairfax, F. Mackay, A. Strasser, et al. 2013. Mcl-1 is essential for the survival of plasma cells. Nat. Immunol. 14: 290-297.
16. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
17. Kozbor, D., A. Moretta, H. A. Messner, L. Moretta, and C. M. Croce. 1987. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J. Immunol. 138: 4128-4132.
18. Nair, J. R., L. M. Carlson, C. Koorella, C. H. Rozanski, G. E. Byrne, P. L. Bergsagel, J. P. Shaughnessy, Jr., L. H. Boise, A. Chanan-Khan, and K. P. Lee. 2011. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment. J. Immunol. 187: 1243-1253.
19. Pellat-Deceunynck, C., R. Bataille, N. Robillard, J. L. Harousseau, M. J. Rapp, N. Juge-Morineau, J. Wijdenes, and M. Amiot. 1994. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 84: 2597-2603.
20. Zhang, X. G., D. Olive, J. Devos, C. Rebouissou, M. Ghiotto-Ragueneau, M. Ferlin, and B. Klein. 1998. Malignant plasma cell lines express a functional CD28 molecule. Leukemia 12: 610-618.
21. Dodson, L. F., J. S. Boomer, C. M. Deppong, D. D. Shah, J. Sim, T. L. Bricker, J. H. Russell, and J. M. Green. 2009. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Mol. Cell. Biol. 29: 3710-3721.
22. Ferguson, S. E., S. Han, G. Kelsoe, and C. B. Thompson. 1996. CD28 is required for germinal center formation. J. Immunol. 156: 4576-4581.
23. Friend, L. D., D. D. Shah, C. Deppong, J. Lin, T. L. Bricker, T. I. Juehne, C. M. Rose, and J. M. Green. 2006. A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant. J. Exp. Med. 203: 2121-2133.
24. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612.
25. van Wijk, F., S. Nierkens, W. de Jong, E. J. Wehrens, L. Boon, P. van Kooten, L. M. Knippels, and R. Pieters. 2007. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins. J. Immunol. 178: 6894-6900.
26. Ribeiro, A. C., I. M. Laurindo, L. K. Guedes, C. G. Saad, J. C. Moraes, C. A. Silva, and E. Bonfa. 2013. Abatacept severely reduces the immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis Care Res. 65: 476-480.
27. Phelps, C. J., S. F. Ball, T. D. Vaught, A. M. Vance, M. Mendicino, J. A. Monahan, A. H. Walters, K. D. Wells, A. S. Dandro, J. J. Ramsoondar, et al. 2009. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 16: 477-485.
28. Horspool, J. H., P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee. 1998. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J. Immunol. 160: 2706-2714.
29. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
30. Akalin, E., A. Chandraker, M. E. Russell, L. A. Turka, W. W. Hancock, and M. H. Sayegh. 1996. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation 62: 1942-1945.
31. Mateo, G., M. A. Montalbán, M. B. Vidriales, J. J. Lahuerta, M. V. Mateos, N. Gutiérrez, L. Rosiñol, L. Montejano, J. Bladé, R. Martínez, et al PETHEMA Study Group; GEM Study Group. 2008. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J. Clin. Oncol. 26: 2737-2744.
32. Bahlis, N. J., A. M. King, D. Kolonias, L. M. Carlson, H. Y. Liu, M. A. Hussein, H. R. Terebelo, G. E. Byrne, Jr., B. L. Levine, L. H. Boise, and K. P. Lee. 2007. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood 109: 5002-5010.
33. Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24: 269-281.
34. Boomer, J. S., and J. M. Green. 2010. An enigmatic tail of CD28 signaling. Cold Spring Harb. Perspect. Biol. 2: a002436.
35. Stephenson, L. M., A. V. Miletic, T. Kloeppel, S. Kusin, and W. Swat. 2006. Vav proteins regulate the plasma cell program and secretory Ig production. J. Immunol. 177: 8620-8625.
36. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620.
37. Shapiro-Shelef, M., K. I. Lin, D. Savitsky, J. Liao, and K. Calame. 2005. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J. Exp. Med. 202: 1471-1476.
38. Semenov, I., C. Akyuz, V. Roginskaya, D. Chauhan, and S. J. Corey. 2002. Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol. Leuk. Res. 26: 271-280.
39. Zhan, F., E. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy, Jr. 2003. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101: 1128-1140.
40. Boomer, J. S., C. M. Deppong, D. D. Shah, T. L. Bricker, and J. M. Green. 2014. Cutting edge: a double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression. J. Immunol. 192: 3465-3469.
41. Tuaillon, N. 2000. Repertoire analysis in human immunoglobulin heavy chain minilocus transgenic, muMT/muMT mice. Mol. Immunol. 37: 221-231.
42. Kallies, A., J. Hasbold, D. M. Tarlinton, W. Dietrich, L. M. Corcoran, P. D. Hodgkin, and S. L. Nutt. 2004. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200: 967-977.
43. Deng, S., T. Yuan, X. Cheng, R. Jian, and J. Jiang. 2010. B-lymphocyte-induced maturation protein1 up-regulates the expression of B-cell maturation antigen in mouse plasma cells. Mol. Biol. Rep. 37: 3747-3755.
44. O'Connor, B. P., V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L. L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199: 91-98.
45. Morgan, M. A., E. Magnusdottir, T. C. Kuo, C. Tunyaplin, J. Harper, S. J. Arnold, K. Calame, E. J. Robertson, and E. K. Bikoff. 2009. Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation. Mol. Cell. Biol. 29: 5813-5827.
46. Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17: 4051-4058.
47. Robillard, N., G. Jego, C. Pellat-Deceunynck, D. Pineau, D. Puthier, M. P. Mellerin, S. Barillé, M. J. Rapp, J. L. Harousseau, M. Amiot, and R. Bataille. 1998. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res. 4: 1521-1526.
48. Murray, M. E., C. M. Gavile, J. R. Nair, C. Koorella, L. M. Carlson, D. Buac, A. Utley, M. Chesi, P. L. Bergsagel, L. H. Boise, and K. P. Lee. 2014. CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood 123: 3770-3779.
49. Jourdan, M., A. Caraux, J. De Vos, G. Fiol, M. Larroque, C. Cognot, C. Bret, C. Duperray, D. Hose, and B. Klein. 2009. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 114: 5173-5181.
50. Jourdan, M., A. Caraux, G. Caron, N. Robert, G. Fiol, T. Rème, K. Bolloré, J. P. Vendrell, S. Le Gallou, F. Mourcin, et al. 2011. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J. Immunol. 187: 3931-3941.
51. Koretzky, G. A., F. Abtahian, and M. A. Silverman. 2006. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6: 67-78.
52. Raab, M., S. Pfister, and C. E. Rudd. 2001. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15: 921-933.
53. Shapiro-Shelef, M., and K. Calame. 2005. Regulation of plasma-cell development. Nat. Rev. Immunol. 5: 230-242.
54. Njau, M. N., J. H. Kim, C. P. Chappell, R. Ravindran, L. Thomas, B. Pulendran, and J. Jacob. 2012. CD28-B7 interaction modulates short- and long-lived plasma cell function. J. Immunol. 189: 2758-2767.